| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e433390a4cb971d108fb8f4734f32992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25800f58682272d151efc9e95ddf0555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9f287e578182e8cb2ab9dc24f745eea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b501a67cbf8dc552776f115a7dc242f2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate |
2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8bde26f35ac99e54b24b26a34cb794e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e3c502f090d86d9beabbb34768cf997
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45eb42baac172228bebe4d704c782e4e |
| publicationDate |
2006-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006006638-A1 |
| titleOfInvention |
DENDRITIC CELL, DRUG CONTAINING THE DENDRITIC CELL, THERAPEUTIC METHOD USING THE DENDRITIC CELL AND METHOD OF CULTURING ϜδT CELL |
| abstract |
It is intended to provide a dendritic cell for effectively activating and/or proliferating ϜδT cells in vivo and/or in vitro; a drug containing the same; a therapeutic method using the dendritic cell; and a method of culturing ϜδT cells using the dendritic cell. An immature dendritic cell originating in peripheral monocyte is pulsed with a bisphosphonate-base bone metabolism-improving agent to thereby impart an ability to activate ϜδT cells. Then it is cultured with cells containing ϜδT cells to thereby activate and/or proliferate the ϜδT cells. Thus, ϜδT cells can be easily proliferated without placing a burden to a patient, which makes it possible to practically carry out an immunological cell therapy with the use of ϜδT cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012191952-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014073050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5384827-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10925936-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2008111430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108513973-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007029689-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008040316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013176403-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609410-B2 |
| priorityDate |
2004-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |